about
Export of microRNAs: A Bridge between Breast Carcinoma and Their Neighboring CellsMicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological DiseasesInvolvement and Clinical Aspects of MicroRNA in OsteosarcomaThe signaling involving in autophagy machinery in keratinocytes and therapeutic approaches for skin diseasesClinical significance of microRNAs in chronic and acute human leukemiaMicroRNAs as regulators of apoptosis mechanisms in cancerTargeting MicroRNA Function in Respiratory Diseases: Mini-ReviewCirculating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomamiRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammationRevealing the Complexity of Breast Cancer by Next Generation SequencingThe functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapysiRNA Versus miRNA as Therapeutics for Gene SilencingGenome-wide analysis of microRNA and mRNA expression signatures in cancerArgonaute 2: A Novel Rising Star in Cancer ResearchThe miR-200 Family: Versatile Players in Epithelial Ovarian CancerPiwi-interacting RNAs in cancer: emerging functions and clinical utilityΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transitionIn-silico modeling of granulomatous diseasesTherapeutic use of microRNAs in lung cancerIdentification of microRNAs in Macaca fascicularis (Cynomolgus Monkey) by Homology Search and Experimental Validation by Small RNA-Seq and RT-qPCR Using Kidney Cortex TissuesMicroRNA-124 enhances response to radiotherapy in human epidermal growth factor receptor 2-positive breast cancer cells by targeting signal transducer and activator of transcription 3Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.Micrornas in prostate cancer: an overview.Prognostic significance of low microRNA-218 expression in patients with different types of cancer: Evidence from published studies.MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.Data Normalization Strategies for MicroRNA Quantification.Integrative methods for analyzing big data in precision medicine.miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression.Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer.microRNA-664 enhances proliferation, migration and invasion of lung cancer cellsMicroRNA-143 suppresses oral squamous cell carcinoma cell growth, invasion and glucose metabolism through targeting hexokinase 2.Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinomamiR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer.Gga-miR-219b targeting BCL11B suppresses proliferation, migration and invasion of Marek's disease tumor cell MSB1Genistein suppresses retinoblastoma cell viability and growth and induces apoptosis by upregulating miR-145 and inhibiting its target ABCE1.IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
P2860
Q26744487-66EE7DAF-6085-4F83-B87F-47F0068B0A2BQ26744819-B2AD02AF-6D41-486F-B1B2-FE7A5F3BD2A1Q26748406-2B9FBF43-0B6C-4498-A48F-68E84619A066Q26748610-C03CE960-018D-4E42-B589-8F05CF042E43Q26749533-5F37DFB3-4C4D-458D-A25C-361AE8980DF5Q26752710-ECFC9975-CA86-4517-9D48-77F5468A98D0Q26766476-D1D2DB07-0C4F-4EA8-A944-5C2B73259A1DQ26767346-E3D7D6F5-8194-4B8F-BFA1-A64DC6B24C07Q26768556-5588A554-1C94-4DAD-BEC6-21872745160CQ26777395-B049ED18-CE64-4C5C-A989-6BA25B90E7B2Q26778301-E5F021B7-2C79-49D0-A259-9F963C3E7193Q26786876-5549A19E-816E-4FC2-82FA-735DA6E30CF5Q26795603-E0905422-58AB-47B9-A919-972BAF9A840AQ26797294-D0DFD394-3228-4743-B1F7-596508A94338Q26799353-08025DAD-59F3-4ED6-BD34-CF382B2EE48DQ28071824-42C8F156-9B18-4E71-B1D3-A85DD4D12DC9Q28077508-8929BD12-588B-4702-94E1-0B6110FA2A7CQ28392685-70EF0F1C-6365-49CD-8223-78B0246194D2Q28395179-0D7E6DB8-0666-4F48-A2AE-16B193A2FFC6Q28550919-FB91CB21-296F-4C4E-B7F4-277A4075CAFFQ28817827-7819F602-D77E-4189-8C29-BB0DFFBF1E46Q29248177-B3D964BA-3DC3-40FD-9C00-111BD192FA32Q29347531-65C39B8E-1C06-45CB-A26B-A2B6A6733C76Q30234658-D5EA5271-2A60-4372-B741-13C5BE8EA0F3Q30245349-D12C0917-194C-4000-94AD-7964ED5EB86FQ30940333-B986E366-4ADC-464D-BEB7-9A2DEAE14354Q30997590-A6A13F2C-8639-4263-90C7-927C394B7D54Q31032576-075B87E4-B374-4502-96D0-B57664774291Q33596743-8BE5E5C5-CA8A-4881-BEFD-FEE0C2492240Q33618363-7F91F82B-EEEF-4554-A55C-7BC288D92A5BQ33677872-69B3BA28-C245-40C4-AF2C-6BF4975563EBQ33687038-8BC34BD9-6C60-4514-9972-60A93E68C418Q33738954-D606F9A3-3777-40B2-8AF0-0A6CCDE1C23CQ33745073-FBB9FB4F-184A-4DB7-9D08-3544B2654114Q33775931-91957319-5FF3-4E10-BDF0-F56A47C39D38Q33820347-92552024-2A4D-4CF2-BC8D-2EF9DDBDB306Q33822461-741BA3FD-A97C-449A-8D80-55CF216D15C4Q33835336-28035E2D-9B25-49C1-9B20-AB1A44048E41Q33884590-C9B069B4-3612-4735-BF5A-59DB2D0067DFQ33889122-28E0E32A-81B8-42B6-AF39-2DC24244DF9D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MicroRNAs in cancer: biomarkers, functions and therapy.
@en
type
label
MicroRNAs in cancer: biomarkers, functions and therapy.
@en
prefLabel
MicroRNAs in cancer: biomarkers, functions and therapy.
@en
P1476
MicroRNAs in cancer: biomarkers, functions and therapy.
@en
P2093
Pier Paolo Peruzzi
Sean Lawler
P304
P356
10.1016/J.MOLMED.2014.06.005
P50
P577
2014-07-12T00:00:00Z